DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01514240 (ClinicalTrials.gov)	February 2012	10/1/2012	Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan	A Multicentre, Double-blind, Randomised, Parallel-group, Phase III Study to Assess Efficacy and Safety of D9421-C 9 mg Versus Mesalazine 3 g in Patients With Active Crohn's Disease (CD) in Japan	Crohn's Disease	Drug: D9421-C capsule 3 mg;Drug: Mesalazine tablets	AstraZeneca	NULL	Completed	15 Years	130 Years	All	123	Phase 3	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01514240
(ClinicalTrials.gov)

February 2012

10/1/2012

Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan

A Multicentre, Double-blind, Randomised, Parallel-group, Phase III Study to Assess Efficacy and Safety of D9421-C 9 mg Versus Mesalazine 3 g in Patients With Active Crohn's Disease (CD) in Japan

Crohn's Disease

Drug: D9421-C capsule 3 mg;Drug: Mesalazine tablets

AstraZeneca

NULL

Completed

15 Years

130 Years

All

123

Phase 3

Japan